英文别名: |
Etoposide;TENIPOSIDE;4'-demethylepipodophyllotoxin-(4,6-o-(r)-ethylidene-beta-d-glucopyranoside);4-demethylepipodophyllotoxin-beta-d-ethylideneglucoside;ETOPOSIDE(RG);4‘-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside);4'-Demethylepipodophyllotoxin 9-(4,6-O-Ethylidene-β-D-glucopyranoside);Demethylepipodophyllotoxin-beta-D-ethylideneglucoside;VP16;VP-16;VP16213;VP-16-213;4′-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside);Etoposide, British Pharmacopoeia (BP) Reference Standard;SCHEMBL4259;Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one-, 9-((4,6-O-ethylidene-beta-D-glucopyranosyl)oxy)5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl), (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-;9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3'',4'''':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one;EINECS 251-509-1;AS-35312;(5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol -5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside;ETOPOSIDE [WHO-IP];ETOPOSIDE [MART.];Demethyl Epipodophyllotoxin Ethylidine Glucoside;NSC141540;ETOPOSIDE [USP IMPURITY];Tox21_110630;VePESID (TN);Eposide;NSC-141540;(5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3'',4'':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside;HSDB 6517;ETOPOSIDE (USP-RS);Epipodophyllotoxin VP-16213;Etoposide,(S);33419-42-0;Etoposide (USAN:USP:INN:BAN:JAN);BRD-K37798499-001-27-2;Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 9-((4,6-O-(1R)-ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-;AB00438905-18;Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside;GTPL6815;BE164434;CAS-33419-42-0;4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin;L01CB01;HMS2096O13;4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside;ETOPOSIDE IMPURITY C (EP IMPURITY);DTXCID601473876;SMR000112002;ETOPOSIDE [JAN];BRD-K37798499-001-05-8;ETOPOSIDE [EP MONOGRAPH];ETOPOSIDE (EP MONOGRAPH);ETOPOSIDE [HSDB];BRD-K37798499-001-02-5;Etoposidum (INN-Latin);ETOPOSIDE (EP IMPURITY);Etoposidum [INN-Latin];Etoposide (VP16);9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4- hydroxy-3,4-dimethyloxyphenyl)furo (3',4'':6,7) naptho-(2,3-d)-1,3-dioxol-6 (5aH)-one;Prestwick3_000396;MLS001074951;(5R,5AR,8AR,9S)-9-((4,6-O-((1R)-ETHANE-1,1-DIYL)-.ALPHA.-D-GLUCOPYRANOSYL)OXY)-5-(4-HYDROXY-3,5-DIMETHOXYPHENYL)-5,8,8A,9-TETRAHYDRO(2)BENZOFURO(5,6-F)(1,3)BENZODIOXOL-6(5AH)-ONE;D00125;(5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside;HMS2232L03;BC... |